Security (S&B/CBRNE) Magazine

SPR 2016

Security & Border Protection and CST & CBRNE Source Book, published jointly, concentrate on WMD response, NGB training, counterterrorism, and border security

Issue link:

Contents of this Issue


Page 15 of 35 14 | S&BP and CST & CBRNE | Spring 2016 "…JPEO-CBD continues to provide CBRN defense rapid response equipment to the DoD units responsible for homeland defense and defense support of civil authorities." establishing a consortium using Other Transaction Authority (OTA) to carry out coordinated research and development on medical, pharmaceutical, and diagnostic technologies. OTA is not a contract or grant; rather it is a less complicated means for DoD, industry, and academia to collaborate on innovative solutions to meet DoD requirements. The JPEO-CBD is also focused on applying to our detection portfolio the technology lessons learned from our recently completed Joint United States Forces Korea Portal and Integrated Threat Recognition (JUPITR) Advanced Technology Demonstration (ATD). The successful JUPITR ATD demonstrated specific detection and analysis capabilities to address the need for biosurveillance on the Korean Peninsula, enhancing the ability of U.S. Forces Korea and the Republic of Korea to respond to biological threats. We also will continue to assess the challenge of non-traditional agents and how best to incorporate defensive capabilities into our portfolio of systems and products where and when appropriate for the Joint Service. Our portfolio also includes the Defense in Depth information assurance program, radiological and nuclear dosimetry and detection, individual protection and decontamination. Lastly, and perhaps most importantly, the JPEO-CBD strives to maintain our readiness to support DoD crisis response for events such as the Ebola outbreak in West Africa in 2014 and 2015 and the neutralization of Syrian chemical warfare agents (CWA) in the Mediterranean Sea in 2014. CST & CBRNE: How have JPEO-CBD efforts influenced work at the National Guard level in preparation for chem- bio attacks and natural disasters? Mr. Bryce: It is important to remember that Department of Defense Strategy for Countering Weapons of Mass Destruction, published in June of 2014, specifically highlights the importance of the consequence management mission. One of the "countering WMD activities and tasks" under the Strategy is to "safeguard the force and manage consequences." Toward that end, the JPEO-CBD continues to provide CBRN defense rapid response equipment to the DoD units responsible for homeland defense and defense support of civil authorities. Our activities include conducting life cycle assessments of fielded Commercial-Off-The-Shelf (COTS) products, identification and evaluation of emerging capabilities, prioritization and fielding of improved systems to meet existing Director's Corner The Advanced Development and Manufacturing Facility, owned and operated by Nanotherapeutics, Inc., is shown in Alachua, Fla. The Department of Defense uses the facility to develop medical countermeasures to protect and treat Service members against chemical, biological, radiological and nuclear attacks and outbreaks of naturally occurring, emerging and genetically engineered infectious diseases. (DoD photo/Released)

Articles in this issue

Links on this page

Archives of this issue

view archives of Security (S&B/CBRNE) Magazine - SPR 2016